Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer.

about

Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer.

Item

http://www.wikidata.org/entity/Q41090975

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Recombinant human TSH stimulat ...... differentiated thyroid cancer.

@en

type

Item

label

Recombinant human TSH stimulat ...... differentiated thyroid cancer.

@en

prefLabel

Recombinant human TSH stimulat ...... differentiated thyroid cancer.

@en

P1476

Recombinant human TSH stimulat ...... differentiated thyroid cancer

@en

P2093

Bong Yun Cha

http://www.w3.org/2001/XMLSchema#string

Dong Jun Lim

http://www.w3.org/2001/XMLSchema#string

Ja Seong Bae

http://www.w3.org/2001/XMLSchema#string

Kwanhoon Jo

http://www.w3.org/2001/XMLSchema#string

Min Hee Kim

http://www.w3.org/2001/XMLSchema#string

Moo Il Kang

http://www.w3.org/2001/XMLSchema#string

Sohee Lee

http://www.w3.org/2001/XMLSchema#string

Yejee Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Differences in physicians' and patients' perception of acute hypothyroid symptoms induced by thyroid hormone withdrawal in thyroid cancer patients: a multicenter survey in Korea.

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective.

Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer.

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.

Recombinant human thyrotropin-stimulated thyroglobulin level at the time of radioactive iodine ablation is an independent prognostic marker of differentiated thyroid carcinoma in the setting of prophylactic central neck dissection.

Serial measurements of serum thyroglobulin in response to recombinant human thyrotropin stimulation.

Combination of initial stimulation thyroglobulins and staging system by revised ATA guidelines can elaborately discriminate prognosis of patients with differentiated thyroid carcinoma after high-dose remnant ablation.

P304

e7512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000007512

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeonghoon Ha

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28723762

http://www.w3.org/2001/XMLSchema#string

P932

5521902

http://www.w3.org/2001/XMLSchema#string